AUSTIN, Texas — The multitrillion-dollar drug industry is trying to disrupt with the kids, and it’s running into a communications gap.

At SXSW, the weeklong TED Talk with a music festival in there somewhere, biotech this week has been trying to elbow its way into a conference that has ceded most of its time to tech, with its promises of a currency revolution, Martian colonization, and a hack for anything that moves.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Illangkoon can scoff at the FDA all he wants but if he wants to sell something with hormones in it he will have to get FDA approval or go bankrupt or go to jail with a lawsuit from the justice department. You can find non-reasoned people anywhere, but I’d never be foolish enough to to buy a medication (especially somethign with hormones in it) and take it if it isn’t regulated. Even if it is topographical in nature. Nice way to mess up your health permentantely.

    “If the product is intended for a therapeutic use, such as treating or preventing disease, or to affect the structure or function of the body, it’s a drug (FD&C Act, 201(g)), or in some cases a medical device (FD&C Act, 201(h)), even if it affects the appearance.”

  • It looks like at SXSW descended a bunch of miracle elixirs barkers, old west style, rather than respectable biotech scientists/entrepreneurs.
    Even Ned David, he spent six years at Berkeley for his PhD publishing only one single modest research article. So, not exactly an outstanding scientific pedigree. But good enough, to get himself a PhD, apparently. And he made money with Kybella, a drug that is nothing more than deoxycholic acid, a substance you could buy from any chemical company, and inject yourself for any foreseeable future, for just a few bucks.
    Surely, very good at making money (or pretending to). Not really, in advancing biotech science and medicine for real.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy